Atara Biotherapeutics, Inc. Profile Avatar - Palmy Investing

Atara Biotherapeutics, Inc.

Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical…

Biotechnology
US, South San Francisco [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

  • Records
  • Forecasts [Soon]
Growth Rates
% YoY
% 3Yr
% 5Yr
% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
% - - Yield
0.00% Payout Ratio
Download
Cash Amount Pay Date
Download
Cash Amount Pay Date
End of ATRA's Analysis
CIK: 1604464 CUSIP: 046513107 ISIN: US0465131078 LEI: - UEI: -
Secondary Listings
ATRA has no secondary listings inside our databases.